News for hackers. Stuff that matters.

A comment on Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval. Parent comment

Re:Third member of U.S. FDA advisory panel resigns over Alzh... by f6v on Friday June 11, 2021 @11:16AM (#27474507)
Big Pharma bad, but making drugs is incredibly costly. Especially in Alzheimers, where so many candidates failed. It's incredible someone is even trying after so many failures.
[ Parent | on HN ]
Re:Third member of U.S. FDA advisory panel resigns over Alzh... by CogitoCogito on Friday June 11, 2021 @11:24AM (#27474596)
That's true, but I don't really see why the drug companies shouldn't pay those costs.
[ Parent | on HN ]
Re:Third member of U.S. FDA advisory panel resigns over Alzh... by alexslobodnik on Friday June 11, 2021 @11:38AM (#27474783)
The second order effects may be that they wouldn't want to even try to develop a drug.

What world do you want to live in? (Rhetorical)

[ Parent | on HN ]
Re:Third member of U.S. FDA advisory panel resigns over Alzh... by mcguire on Friday June 11, 2021 @02:25PM (#27476843)
The third order effects may be continued erosion of respect for the federal government's regulatory process. Tread carefully. (And make lots of money while you can.)
[ Parent | on HN ]
Re:Third member of U.S. FDA advisory panel resigns over Alzh... by jhayward on Friday June 11, 2021 @02:50PM (#27477106)
And blowing out the drug budget for medicare for a very expensive but futile treatment.
[ Parent | on HN ]
Re:Third member of U.S. FDA advisory panel resigns over Alzh... by tinus_hn on Saturday June 12, 2021 @02:37AM (#27482150)
If you say they should pay the costs, they should also reap the rewards, so in that case you have to accept that drugs are really expensive.
[ Parent | on HN ]